Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
- 1 May 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Cancer
- Vol. 8 (5), 351-360
- https://doi.org/10.1038/nrc2373
Abstract
This Review deals with recent progress in the immunotherapy of established (pre)malignant disease of viral or non-viral origin by synthetic vaccines capable of inducing robust T-cell responses. The most attractive vaccine compounds are synthetic long peptides (SLP) corresponding to the sequence of tumour viral antigens or tumour-associated non-viral antigens. Crucial to induction of therapeutic T-cell immunity is the capacity of SLP to deliver specific cargo to professional antigen-presenting cells (dendritic cells (DC)). Proper DC activation then induces the therapeutic CD4+ and CD8+ T-cell responses that are associated with regression of established (pre)malignant lesions, including those induced by high-risk human papilloma virus.Keywords
This publication has 100 references indexed in Scilit:
- DNA vaccines: precision tools for activating effective immunity against cancerNature Reviews Cancer, 2008
- Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNature Reviews Immunology, 2007
- Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activationProceedings of the National Academy of Sciences of the United States of America, 2007
- Rapid Identification of Malaria Vaccine Candidates Based on α-Helical Coiled Coil Protein MotifPLOS ONE, 2007
- Cancer Vaccines: Moving Beyond Current ParadigmsClinical Cancer Research, 2007
- DC-based cancer vaccinesJCI Insight, 2007
- Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cellsExpert Review of Vaccines, 2007
- Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus modelVaccine, 2005
- CD4+ and CD8+ T-cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes: Implications for HLA class I and II allelic linkage to disease susceptibilityHuman Immunology, 1999
- Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative TumorsThe Journal of Experimental Medicine, 1998